These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 35439579)
1. Defining the Role of Anti- and Pro-inflammatory Outcomes of Interleukin-6 in Mental Health. García-Juárez M; Camacho-Morales A Neuroscience; 2022 Jun; 492():32-46. PubMed ID: 35439579 [TBL] [Abstract][Full Text] [Related]
2. The balance of interleukin (IL)-6, IL-6·soluble IL-6 receptor (sIL-6R), and IL-6·sIL-6R·sgp130 complexes allows simultaneous classic and trans-signaling. Baran P; Hansen S; Waetzig GH; Akbarzadeh M; Lamertz L; Huber HJ; Ahmadian MR; Moll JM; Scheller J J Biol Chem; 2018 May; 293(18):6762-6775. PubMed ID: 29559558 [TBL] [Abstract][Full Text] [Related]
3. Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. Nishimura R; Moriyama K; Yasukawa K; Mundy GR; Yoneda T J Bone Miner Res; 1998 May; 13(5):777-85. PubMed ID: 9610741 [TBL] [Abstract][Full Text] [Related]
4. Experiment-based computational model predicts that IL-6 classic and trans-signaling exhibit similar potency in inducing downstream signaling in endothelial cells. Song M; Wang Y; Annex BH; Popel AS NPJ Syst Biol Appl; 2023 Sep; 9(1):45. PubMed ID: 37735165 [TBL] [Abstract][Full Text] [Related]
5. Interleukin-6: A Masterplayer in the Cytokine Network. Uciechowski P; Dempke WCM Oncology; 2020; 98(3):131-137. PubMed ID: 31958792 [TBL] [Abstract][Full Text] [Related]
6. Role of interleukin 6 (IL-6)/IL-6R-induced signal tranducers and activators of transcription and mitogen-activated protein kinase/extracellular. Legendre F; Bogdanowicz P; Boumediene K; Pujol JP J Rheumatol; 2005 Jul; 32(7):1307-16. PubMed ID: 15996070 [TBL] [Abstract][Full Text] [Related]
7. Function and proteolytic generation of the soluble interleukin-6 receptor in health and disease. Schumertl T; Lokau J; Rose-John S; Garbers C Biochim Biophys Acta Mol Cell Res; 2022 Jan; 1869(1):119143. PubMed ID: 34626681 [TBL] [Abstract][Full Text] [Related]
8. Inhibition of classic signaling is a novel function of soluble glycoprotein 130 (sgp130), which is controlled by the ratio of interleukin 6 and soluble interleukin 6 receptor. Garbers C; Thaiss W; Jones GW; Waetzig GH; Lorenzen I; Guilhot F; Lissilaa R; Ferlin WG; Grötzinger J; Jones SA; Rose-John S; Scheller J J Biol Chem; 2011 Dec; 286(50):42959-70. PubMed ID: 21990364 [TBL] [Abstract][Full Text] [Related]
9. Activation of the JAK/STAT3 and PI3K/AKT pathways are crucial for IL-6 trans-signaling-mediated pro-inflammatory response in human vascular endothelial cells. Zegeye MM; Lindkvist M; Fälker K; Kumawat AK; Paramel G; Grenegård M; Sirsjö A; Ljungberg LU Cell Commun Signal; 2018 Sep; 16(1):55. PubMed ID: 30185178 [TBL] [Abstract][Full Text] [Related]
10. Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro. Flynn CM; Garbers Y; Düsterhöft S; Wichert R; Lokau J; Lehmann CHK; Dudziak D; Schröder B; Becker-Pauly C; Rose-John S; Aparicio-Siegmund S; Garbers C Sci Rep; 2020 Dec; 10(1):21612. PubMed ID: 33303781 [TBL] [Abstract][Full Text] [Related]
11. Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Jougasaki M; Ichiki T; Takenoshita Y; Setoguchi M Br J Pharmacol; 2010 Mar; 159(6):1294-303. PubMed ID: 20136831 [TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 and its receptors: a highly regulated and dynamic system. Wolf J; Rose-John S; Garbers C Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424 [TBL] [Abstract][Full Text] [Related]
13. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Atreya R; Mudter J; Finotto S; Müllberg J; Jostock T; Wirtz S; Schütz M; Bartsch B; Holtmann M; Becker C; Strand D; Czaja J; Schlaak JF; Lehr HA; Autschbach F; Schürmann G; Nishimoto N; Yoshizaki K; Ito H; Kishimoto T; Galle PR; Rose-John S; Neurath MF Nat Med; 2000 May; 6(5):583-8. PubMed ID: 10802717 [TBL] [Abstract][Full Text] [Related]
15. Role of the IL-6 classic- and trans-signaling pathways in corneal sterile inflammation and wound healing. Ebihara N; Matsuda A; Nakamura S; Matsuda H; Murakami A Invest Ophthalmol Vis Sci; 2011 Nov; 52(12):8549-57. PubMed ID: 21989726 [TBL] [Abstract][Full Text] [Related]
16. Involvement of Spinal IL-6 Trans-Signaling in the Induction of Hyperexcitability of Deep Dorsal Horn Neurons by Spinal Tumor Necrosis Factor-Alpha. König C; Morch E; Eitner A; Möller C; Turnquist B; Schaible HG; Ebersberger A J Neurosci; 2016 Sep; 36(38):9782-91. PubMed ID: 27656018 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic blockade of the interleukin-6 receptor (IL-6R) allows sIL-6R generation by proteolytic cleavage. Prenissl N; Lokau J; Rose-John S; Haybaeck J; Garbers C Cytokine; 2019 Feb; 114():1-5. PubMed ID: 30557809 [TBL] [Abstract][Full Text] [Related]
18. IL-6 trans-signaling via the soluble IL-6 receptor: importance for the pro-inflammatory activities of IL-6. Rose-John S Int J Biol Sci; 2012; 8(9):1237-47. PubMed ID: 23136552 [TBL] [Abstract][Full Text] [Related]
19. Context-dependent IL-6 potentiation of interferon- gamma-induced IL-12 secretion and CD40 expression in murine microglia. Lin HW; Levison SW J Neurochem; 2009 Nov; 111(3):808-18. PubMed ID: 19712053 [TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 induces both cell growth and VEGF production in malignant mesotheliomas. Adachi Y; Aoki C; Yoshio-Hoshino N; Takayama K; Curiel DT; Nishimoto N Int J Cancer; 2006 Sep; 119(6):1303-11. PubMed ID: 16642474 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]